Breakthrough Dividend: Appendix B

Reuven Alster, Marketing Manager, YISSUM

Yair Amitai, Director, Israel Center for R&D (MATIMOP)

Ed Chait, Vice President for Business Development, Intergen*

Ilan Chet, Vice President for R&D, Hebrew University

Jonathan Cohen, President, U.S.-Israel Biotechnology Council*

Ruth Cohen, Scientific Director, HY-Labs

Shabtay Dover, Director, Hebrew University Authority for R&D

David Jonas, Vice President for Strategic Initiatives, Baxter Travenol*

Rick Gildersleeve, Embrex*

Ora Horovich, Scientific Product Manager, Savyon Diagnostics

Uri Litvin, Managing Director, YISSUM

Elli Malki, Manager, Business Development, Hadasit, Hadassah Medical Org.

Ben McDaniel, Professor, North Carolina State*

Dennis McNamara, APEX*

Hamutal Meiri, Coordinator, National Committee on Biotechnology

Gershon Metzger, Chief Scientist, Ministry of Science and the Arts

Ed Noga, Professor, North Carolina State*

Moshe Perkal, President, Pharmaceuticals Associates (U.S., Israel)

Tom Petes, Professor, University of North Carolina*

Mira Richman, Director, Dept. Healthcare, Israel Export Institute

Eleanor Slayter, Coordinator, U.S. Research Grants

Ohad Zukerman, Manager, Zeraim Seed Growers, Ltd.

Israeli Industry Source, Anonymous

* Interviewed by Dr. Mitchell Bard